Beximco Pharmaceuticals Statistics

Total Valuation

Beximco Pharmaceuticals has a market cap or net worth of BDT 31.54 billion. The enterprise value is 41.18 billion.

Market Cap	31.54B
Enterprise Value	41.18B

Important Dates

The next estimated earnings date is Monday, November 4, 2024.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

Beximco Pharmaceuticals has 446.11 million shares outstanding.

Shares Outstanding	446.11M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.07%
Owned by Institutions (%)	3.88%
Float	297.32M

Valuation Ratios

The trailing PE ratio is 5.92 and the forward PE ratio is 5.75. Beximco Pharmaceuticals's PEG ratio is 0.30.

PE Ratio	5.92
Forward PE	5.75
PS Ratio	0.73
PB Ratio	0.68
P/FCF Ratio	4.98
PEG Ratio	0.30

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.31, with an EV/FCF ratio of 6.50.

EV / Earnings	7.72
EV / Sales	0.96
EV / EBITDA	4.31
EV / EBIT	5.31
EV / FCF	6.50

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.15.

Current Ratio	1.80
Quick Ratio	0.45
Debt / Equity	0.15
Debt / EBITDA	0.78
Debt / FCF	1.17
Interest Coverage	6.82

Financial Efficiency

Return on equity (ROE) is 10.99% and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE)	10.99%
Return on Assets (ROA)	6.97%
Return on Capital (ROIC)	8.37%
Revenue Per Employee	7.56M
Profits Per Employee	935,153
Employee Count	5,700
Asset Turnover	0.62
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-50.48%
50-Day Moving Average	78.97
200-Day Moving Average	114.20
Relative Strength Index (RSI)	46.52
Average Volume (20 Days)	551,986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Beximco Pharmaceuticals had revenue of BDT 43.08 billion and earned 5.33 billion in profits. Earnings per share was 11.95.

Revenue	43.08B
Gross Profit	18.63B
Operating Income	7.75B
Pretax Income	6.92B
Net Income	5.33B
EBITDA	9.44B
EBIT	7.75B
Earnings Per Share (EPS)	11.95

Full Income Statement

Balance Sheet

The company has 1.73 billion in cash and 7.43 billion in debt, giving a net cash position of -5.70 billion or -12.77 per share.

Cash & Cash Equivalents	1.73B
Total Debt	7.43B
Net Cash	-5.70B
Net Cash Per Share	-12.77
Equity (Book Value)	50.41B
Book Value Per Share	104.17
Working Capital	9.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.37 billion and capital expenditures -2.04 billion, giving a free cash flow of 6.34 billion.

Operating Cash Flow	8.37B
Capital Expenditures	-2.04B
Free Cash Flow	6.34B
FCF Per Share	14.21

Full Cash Flow Statement

Margins

Gross margin is 43.24%, with operating and profit margins of 18.00% and 12.37%.

Gross Margin	43.24%
Operating Margin	18.00%
Pretax Margin	16.07%
Profit Margin	12.37%
EBITDA Margin	21.91%
EBIT Margin	18.00%
FCF Margin	14.71%

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 4.83%.

Dividend Per Share	3.50
Dividend Yield	4.83%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	29.69%
Buyback Yield	n/a
Shareholder Yield	4.83%
Earnings Yield	16.90%
FCF Yield	20.09%

Dividend Details

Stock Splits

The last stock split was on November 26, 2020. It was a forward split with a ratio of 1.1.

Last Split Date	Nov 26, 2020
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a